Novel Treatments for Brain Tumors
A special issue of Neurology International (ISSN 2035-8377). This special issue belongs to the section "Brain Tumor and Brain Injury".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 296
Editors
Interests: malignant and rare primary CNS tumors; malignant and treatment-refractory meningiomas, ependymomas, and medulloblastomas; BRAF-altered CNS tumors; histone-mutated gliomas, especially in adolescent and young adult (AYA) patient populations, clinical trials, and in translational research
Interests: pituitary adenoma; craniopharyngioma; pregnancy in neurosurgery; brain tumors
Special Issue Information
Dear Colleagues,
Brain tumors are a diverse group of diseases encompassing primary and secondary tumors. According to the Central Brain Tumor Registry of the United States (CBTRUS), primary malignant neoplasms account for 14% of all brain tumors, with the overall incidence of brain tumors increasing over time. Successful management of these tumors requires a multidisciplinary approach including neurosurgeons, neurooncologists, radiation oncologists, neuropathologists, neuroradiologists, and other specialists. Current challenges include the management of multiply recurrent pituitary adenoma, the role of BRAF-targeted therapy in the treatment of papillary craniopharyngiomas, tectal low-grade gliomas, and recurrent chordomas. Rapid advances in genomics and our understanding of cancer biology are driving the development of novel therapeutic approaches that promise to improve outcomes in this patient population.
The aim of this Special Issue is to review and discuss the latest treatments for malignant and non-malignant primary brain tumors, with a focus on treatment outcomes, the optimal timing of novel therapies, and impact on patient quality of life. This Special Issue will serve as a reference and guide that spans across multiple disciplines surrounding the care of patients with brain tumors. We invite submissions that discuss novel therapeutic options for primary malignant or non-malignant brain tumors and their impact on outcomes, socio-economic burden, and national and global accessibility.
Dr. Byram Ozer
Dr. Olabisi Sanusi
Dr. Sushant Puri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neurology International is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- primary brain tumor
- glioblastoma
- craniopharyngioma
- meningioma
- low-grade glioma
- tectal glioma
- precision oncology
- chordoma
- pituitary adenoma
- pituitary carcinoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
